Finishing wave 3 - target 140 dollar region

NASDAQ:PACB   Pacific Biosciences of California, Inc
PACB is finishing wave 3 and is on its last leg (wave 5 in this wave 3). Wave 3 is generally 1.618 the length of wave 1, which puts the target at around 140 dollars over the next several months. This is a great investment for the long term as well since it will likely have more upside in the years to come in the form of wave 5 and has tailwinds from gene editing breakthroughs.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.